These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5378451)

  • 21. Disappearance of measles antibody in Thai infants after birth.
    Vanprapar N; Chavalittamrong B; Chearskul S; Pimolpan V
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):488-90. PubMed ID: 6673124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemagglutination inhibition reaction with measles antigen in rinderpest. I. Its use in diagnosis].
    Bögel K; Provost A; Enders-Ruckle G
    Zentralbl Bakteriol Orig; 1966 Jan; 199(1):1-19. PubMed ID: 6010536
    [No Abstract]   [Full Text] [Related]  

  • 24. A serological study of children vaccinated against measles.
    Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988
    [No Abstract]   [Full Text] [Related]  

  • 25. [Detection of measles antibodies using the indirect hemagglutination test].
    Smorodinova IP; Miroshnikova NK; Kashkina GB; Baiar GA; Noskov FS
    Tr Inst Im Pastera; 1981; 56():115-7. PubMed ID: 6764965
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemagglutination inhibiting antibodies to measles, rubella, and parotitis. Study of their prevalence in a community of the Mexican plateau].
    Golubjatnikov R; Leppla L; Filloy L
    Salud Publica Mex; 1970; 12(5):603-9. PubMed ID: 5509277
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with the live measles vaccine].
    Vivell O; Lips G
    Arch Kinderheilkd; 1967; 176(2):156-63. PubMed ID: 5592896
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 29. Measles outbreak in a junior high school in November-December 1998.
    Sakata H; Kouhara T; Takeda M; Yamada A; Ohkubo S; Sasaoka Y; Tashiro M
    Jpn J Infect Dis; 1999 Aug; 52(4):172-3. PubMed ID: 10592902
    [No Abstract]   [Full Text] [Related]  

  • 30. [Measles antibodies in selected groups of people. (Kindergarten teachers, pregnant cases, measles patients with complications)].
    Kahlow A
    Zentralbl Bakteriol Orig; 1966 Oct; 201(2):153-65. PubMed ID: 5994743
    [No Abstract]   [Full Text] [Related]  

  • 31. [Detection and titration of hemagglutination-inhibiting antibodies against measles virus in a sample of the population of Rome].
    Balestrieri A; Russo V
    Arch Ital Sci Med Trop Parassitol; 1967; 48(7):187-98. PubMed ID: 5609910
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies of specific measles prevention].
    Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
    Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the synthesis of basic proteins and antigenic components in measles virus infected cells.
    Polna I; Rzendowska F; Beker J; Hirszfeld G; Sadowski W
    Acta Microbiol Pol; 1980; 29(3):273-84. PubMed ID: 19852113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
    Topciu V; Moldovan E; Csaky N; Băcilă E
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated immune reactions in measles.
    Kańtoch M; Abramow-Newerly W; Jankowski M; Imbs D; Litwińska B; Stepień R; Slowińska I; Kubica J; Boguslawska J
    Acta Virol; 1980 Mar; 24(2):119-26. PubMed ID: 6107020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S; Munţiu A; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.